Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,966
Closed -$2.63M 1761
2026
Q1
$2.63M Buy
6,966
+1,540
+28% +$660K 0.05% 590
2025
Q4
$2.32M Sell
5,426
-2,037
-27% -$887K 0.05% 554
2025
Q3
$3.34M Sell
7,463
-2,374
-24% -$1.08M 0.08% 358
2025
Q2
$4.79M Buy
+9,837
New +$5.61M 0.12% 235
2025
Q1
Sell
-1,577
Closed -$835K 1244
2024
Q4
$835K Buy
+1,577
New +$889K 0.06% 501
2024
Q3
Sell
-2,812
Closed -$1.53M 1358
2024
Q2
$1.53M Buy
2,812
+2,364
+528% +$1.35M 0.08% 333
2024
Q1
$288K Buy
+448
New +$272K 0.02% 971
2023
Q1
Sell
-471
Closed -$240K 1211
2022
Q4
$240K Buy
+471
New +$229K 0.04% 752
2022
Q3
Sell
-707
Closed -$332K 994
2022
Q2
$332K Buy
+707
New +$345K 0.04% 553
2021
Q3
Sell
-893
Closed -$424K 672
2021
Q2
$424K Buy
+893
New +$429K 0.11% 304

Other funds holding CHE

Y-Intercept (HK)'s CHE Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Chemed (CHE) in Q2 2026, closing a stake of 6,966 shares — an estimated $2.63M sold.

Y-Intercept (HK) first reported a position in CHE in Q2 2021 and held it in 10 quarters. The position peaked at $4.79M in Q2 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 6,966 Chemed shares in Q2 2026, an estimated $2.63M.
  • Y-Intercept (HK) first reported a position in Chemed in Q2 2021 and held it in 10 quarters.
  • Y-Intercept (HK)'s Chemed position peaked at $4.79M in Q2 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.